Building a Quantitative Case for the Medical and Economic Potential of Symptom Tracking Tools
description
Transcript of Building a Quantitative Case for the Medical and Economic Potential of Symptom Tracking Tools
-
SYMPTOM TRACKING TOOLS
Building a Quantitative Case for the Medical
and Economic Potential of Symptom Tracking
Tools
Imran A. Khan
Abstract--Since 2007, the Centers for Medicare
and Medicaid Services (CMS) have devised
outcome measures that focus on high quality
patient care. A hospital readmission rate over a
30-day period is one such measure that allows
medical professionals and patients to critically
appraise health care providers and provides a
framework for hospitals to meet quality control
standards. Hospital readmission rates, especially
for elderly patients, are a significant concern in
U.S. Healthcare since 1 in 5 patients on
Medicare & Medicaid is re-admitted to hospitals
within 30 days of their treatment. This is
currently costing the U.S. government over $17
billion per year and is projected to increase. On
October 2012, the U. S. government started
implementing penalties, which could reach as
high as 40 million, to hospitals with high rates of
readmission over a 30-day period. The objective
of this paper is to analyze the efficacy of the use
of symptom tracking tools and to build a
quantitative case for the medical and economic
potential of symptom tracking tools using the
30-day readmission rate metric.
Keywords - Symptom Tracking Tools, Center for
Medicare and Medicaid Services, Electronic Health
Records, 30-day Readmission, Excess Readmission
Ratio.
I. INTRODUCTION
One of the most important and controversial
issues affecting todays American healthcare system is how to cost-effectively improve on
hospital readmission. Patients readmission shortly after they are discharged from the hospital is
widely cited as a significant contributor to the
decreasing poor quality of care and rising
healthcare costs [1] [2] [3]. It is reported that 1 in 5
Medicare patients discharged from hospital are re-
admitted within 30 days of their treatment [4].
Patients are therefore, forced to incur additional
costs to cater for such bills. In 2004, the total cost
spend on re-hospitalization was estimated at $17.5
billion [5]. Currently, it is estimated that Medicare
alone spends close to $15 billion annually on re-
hospitalizations [6]. These figures only accounts
for the cost incurred due to readmission.
Dissatisfaction and distress experienced by patients
who find themselves readmitted in hospitals and
the high intangible readmissions strain put on
hospitals is not taken into account in these tallies.
However, as noted by Optum [7], three-quarters of
these hospital readmissions could easily be avoided
with better care and the US Congress, insurance
companies as well as hospitals have taken notice of
this.
Although it is still not clear whether these
readmissions can be preventable, there is evidence
that their causes vary widely. While in certain cases
conditions of patients can unavoidably worsen,
studies have shown that more than 50% of the
patients are often readmitted quickly because of
errors that may have occurred in their first hospital
visit. As revealed by the Agency for Healthcare
Research and Quality's (AHRQ), 1 in 5 patients has
an adverse event or a complication after they are
drastically discharged from hospitals, increasing
their likelihood of readmission [2].
Measures have been put in place to ensure the
rate of hospital readmission decreases. The two key
measures were: the introduction of Electronic
Health Records (EHRs) and the Center for
Medicare and Medicaid (CMS) by the US
Congress. In 2012, the US Congress enacted a
federal healthcare law under which the Center for
Medicare and Medicaid (CMS) services were
mandated to start using the 30-day cutoff to
penalize hospitals whose readmission rates were
found to be higher than the required readmission
rates. The law also allowed the CMS to refuse
paying for selected diagnoses that may have
occurred during the 30-day cutoff. CMS was also
mandated to closely monitor global payment
systems and to start pilot projects aimed at looking
at reimbursement per diagnosis. The US Congress
also enacted the HITECCH Act, which is part of
the 2009 American Recovery and Reinvestment
Act, to ensure hospitals make meaningful use of
symptom tracking tools to help improve patient
care. By implementing the use of symptom
tracking tools, hospitals can store, as well as
retrieve patients detailed information to be used by patients and health care providers across settings
and during patient hospitalizations. Since these two
laws came into practice, there has been increased
adoption of programs aimed at reducing
readmission rate. More than before, hospitals are
-
SYMPTOM TRACKING TOOLS 2
focusing on organizing their approaches in the way
they assess risk for readmission. They are
increasingly prioritizing areas that need
intervention and developing and applying
appropriate strategies for prevention. This move
has ensured a significant increase in the number of
Americans using electronics applications to track
their health. One of these electronic applications is
the symptom tracking tool. What remains unclear,
however, is whether electronic applications can
effectively serve the purpose. The objective of this
paper is to analyze the efficacy of the use of
symptom tracking tools and to build a quantitative
case for the medical and economic potential of
symptom tracking tools using the 30-day
readmission rate metric.
II. THE MAIN CAUSES OF READMISSION
Understanding the root causes of readmission is
the starting point to formulating policies to help
keep readmissions to a minimum. However,
findings the root causes of patient rebounds can be
one of the most complex undertakings. There exist
many factors that can contribute to readmissions. In
a root cause analysis, such factors must be
accounted for. As noted by Hunter, Nelson, &
Birmingham [6] to ascertain the main causes of
readmission, there are multiple questions to be
asked: How was the patients way of managing his or her condition prior to his or her hospitalization?
What happened during the patients period of hospitalization? Was the patient following proper
orders from their physician when taking prescribed
medication? Was the patient regularly visiting the
physician or primary care?
With a view to validate the hypothesis around the
main causes of readmission, researchers (e.g., Hill
physicians) used a specific population from
Accountable Care Organizations (ACO) hospital partners to carry out a root-cause analysis [8]. The
sample population included discharge planners,
doctors, hospital nurses, and other team members
working in these health care centers. After
discussing individual readmissions, the hospital
system and Hill Physicians were able to decrease
its 30-day commercial readmission percentage by
20% in one year - from 5.4% to 4.3% - by
modifying inpatient and outpatient system and
clinical processes. They also sought patients perspective over the root cause of readmission.
Readmitted patients were interviewed in order to
gain insight on their thoughts concerning what led
them to be readmitted to the hospital, what they did
not understand about instructions of their
discharge, and what they would have done
differently in order to achieve ideal outcomes. This
study found clinical and non-clinical factors as two
important factors that determine whether a patient
is readmitted to the hospital or not. According to
this studys findings, clinical factors leading to patient rebounds fall under three categories of
patients: ones that do not follow up with their
physicians after leaving the hospital, ones that
either adhere to harmful regimen or do not follow
the prescribed medication regimen, and ones that
are often in worse condition with more healthcare
needs. Other studies (e.g., Coffey [9] and
continuity-care-programs) support this finding
suggesting that patients seen by a physician shortly
after the inpatient discharge have a less likelihood
of rebounding. Coffey [9] further asserts that many
patients, in particular those taking multiple
medications, often get confused about what to take
and when to take it. He indicates that such patients
follow medications regimens based on faulty and
misleading medication reconciliation. With regard
to the issue of patients becoming sicker with other
care demands, Optum [7] noted that as patients stays in the hospital get shorter, they are transferred
to lower levels of care, causing them to experience
multiple transitions between nursing homes, their
home, SNFs, and rehabilitation hospitals. This
leads to limited continuity of care, and fragmented
provider communication.
The study revealed that non-clinical causes of
readmission offer significant challenges and that
these types of factors are the most difficult to
address. Optum [7] noted that non-clinical
readmission causes require a level of patient
support and engagement. These non-clinical
readmission causes are categorized as follows: (1)
medical literacy in patients is substandard, (2)
patients lack adequate support structure, and (3)
information is not relayed to care providers early
enough. The study found that when discharge
instructions are shared among patients in a
standardized procedure, those who convey the
information do not ensure that the patients have a
background that can help them understand what is
being told to them. According to this study, this
problem is caused by cultural beliefs, medical
context issues and language barriers. It also
emerged that some patients rebound to emergency
or hospital departments because they do not have
the necessary support from close friends or family
members who can help them follow the proper
post-discharge program. It was also revealed that
lack of interoperability standards have continued to
impede information from being shared across
outpatient and inpatient settings.
Minott [10] categorized factors contributing to
patient rebound into four criteria: poor transitions
between different care settings and providers, or
poor quality care, the discharging of patients to
inappropriate settings, the failure to provide
patients with adequate resources of information to
-
SYMPTOM TRACKING TOOLS 3
ensure continuous progression, and the lack of
seamless communication, coordinated care, and
information exchange between community-based
providers and inpatient.
III. COST OF READMISSION
Medicare data on patient rebounds and
readmissions shows both the size of opportunity
and the scale of the problem that is facing multiple
efforts underway and the Medicare program. Data
from the Centers for Medicare and Medicaid
Services (CMS) [11] reveals that in 2010, Medicare
payment from readmission rate was 19.2%. It
shows that just under 10 million admissions, there
were about 1.91 million readmissions. This report
indicates that $17.5 billion was spent on
readmission costs with 99% of this cash being
spent on inpatient. It also reveals that out of more
than 30 million beneficiaries of Medicare, less than
4% had a readmission. As indicated in Table 1,
from 2007 to 2008, the national readmission rate
remained relatively unchanged (Table 1). Between
2007 and 2010, the actual numbers of readmissions
reduced by approximately 75,000. However, there
was a proportional reduction in the total index
admissions. This caused the readmission rate to
remain relatively constant (Table 1). Data on the
2011 readmission rate shows that there was no
significant change in the readmission rate from the
2010 figures [12]. Just as in 2010, both index
readmissions and admissions appear to maintain
the downward trend in 2011 (Table 02). Since
2012, the average national hospital readmission
rate of Medicare has remained relatively constant
over time (Centers for Medicare and Medicaid
Services, 2012). In 2012, Centers for Medicare and
Medicaid Services (CMS) [12] indicated that the
average national hospital readmissions rate was
19%, with almost 4% of the beneficiaries of
Medicare reported to have two or more
readmissions in a period of 30 days. Findings of
Lauren, Wier, et al [13] indicate that commercial
payers 30-day readmission rate ranged from 10.1% to 11.9%. In regards to age-bound
grouping, the study found that adults age ranging
between 18 and 44 had a readmission rate of
10.1%, while adults whose age ranged between 45
and 64, had average readmission rate of 11.9%.
Optimum [14] indicated that of 6.3 million
commercially insured patients, the average
commercial readmission costs was 37% higher than
the average hospital admission. These high costs of
readmission informed payers such as Aetna, United
Healthcare and WellPoint to introduce initiatives
that helped reduce readmission rates among their
insured populations [15][16][17]. Other studies
(e.g., [18][19]) have indicated that in Medicare,
expenditure on inpatient care accounts for 38% of
total spending, with readmission contributing
significantly to this cost. Medicare Payment
Advisory Commission [20] indicates that 18% of
patients discharged from hospitals are readmitted
within 30 days of their discharge. This study
indicates that this accounts for $15 billion in
spending.
TABLE 1: NATIONAL READMISSION RATE FROM
2007 TO 2010 (DATA OBTAINED FROM CMS)
YEAR 2007 2008 2009 2010 07-10
CHANGE
READMISSION
RATE (%)
19.2 19.3 19.4 19.2 0.1
INDEX
ADMITS PER
1,000
BENEFITS
329 327 320 316 -3.9
READMITS
PER, 1000
BENEFITS
63 63 62 61 -3.8
TABLE 2: NATIONAL READMISSION RATE FROM
2007 TO 2010 (DATA OBTAINED FROM CMS)
YEAR 2010 2011
INDEX ADMITS
PER 1000 BENES
316 308
READMISSION
RATE (%)
19.2 19.0
It is evident that readmissions increase the
costs of health care and negatively impact the
quality outcome of health care.
IV. HOW PREVENTABLE READMISSIONS ARE
Readmissions are generally costly yet they can
be prevented. It is indicated that in 2003 and 2004,
over 2.4 million patients were readmitted within 30
days of their discharge [21]. Jencks [4] indicates
that currently, Medicare alone spends close to $15
billion annually on re-hospitalizations.
Commonwealth Fund [22] indicates that if national
rates of hospital readmission were reduced to a
level where top-performing regions could achieve,
Medicare could save about $ 1.9 billion annually
[22]. This is supported by the Medicare Payment
Advisory Commission (MedPAC) [20], which
shows that in 2005, 17.7% of patients were re-
hospitalized within a period of 30 days of their
-
SYMPTOM TRACKING TOOLS 4
discharge and that 77% of these reported
readmissions were potentially preventable. The
estimated average payment for a potentially preventable readmissions was $7,200 per person [20]. Other studies e.g., [32] have estimated the
rate of preventable readmissions to be as high as 76
percent and as low as 12 percent. This study [32]
shows that readmissions resulting from inadequate
transitional care or poor quality of care may be
preventable, but those readmissions that result from
the worsening of chronic diseases or progression of
diseases are unavoidable. In view of randomized
controlled studies, readmissions rates could be
reduced if improvements were made in the
following key areas: communication between
patients, clinicians, and the patients caregivers, pre-discharge assessment, coordination of care
after the patients have been discharged from
hospitals, and patient education. There is also
evidence that readmission rates can be reduced by
putting in place quality-of care initiatives. This
illustrates the impact that hospital practices can
have on the readmission rates. Randomized trials
have successfully reduced rates of 30-day
readmissions by 20% - 40% [10] [23].
Other studies have argued that whether
readmissions can be prevented or not depends on
whether those readmissions are planned or
unplanned. The Medicare Payment Advisory
Commission (MedPAC) (2) categorizes
readmissions into three categories: planned
readmissions; unplanned readmissions, and
readmissions that are unrelated to the cause of
initial hospitalization. Some planned readmissions
are unavoidable since they may be due to patients preferences, natural progression of a disease, or
accepted treatment protocol. On the contrary the
unplanned readmissions, especially those that are
related to patients initial admission, can potentially
be avoided. The unplanned readmission may occur
as a result of a hospital having lapsed in providing
patients with the right treatment or care at the right
time. The majority (90%) of hospital readmissions
are due to unplanned complications while the
remaining 10% of the readmissions are planned. It
is indicated that missed hand-offs from outpatient
to inpatient care or lack of adequate primary
infrastructure can lead to increased unplanned
readmission.
In other studies, it has been suggested that
readmissions can be prevented by putting in place
certain measures. These measures vary from one
hospital to another. However, the widely suggested
prevention methods include: (1) tracking patients
symptoms using symptom tracking tools, (2)
reviewing cases of readmission to check if some of
the readmissions could have been prevented, (3)
checking the risk of readmission for each patient,
(4) using consistent processes for discharging
patients from hospitals that include ensuring that
patients understand instructions and medication
they are given, (5) arranging ongoing
appointments, prompt follow-ups, and
physiotherapy with the general practitioner , and
(6) monitoring hospital data on patient discharge to
ensure the rate of unplanned readmissions does not
increase. Furthermore, effective discharge plans
can help prevent unplanned readmissions. This can
be achieved by giving patients the care instructions
they need after a hospital stay and by helping
patients recognize symptoms that may require
immediate medical attention. In fact, as recent
CMS data shows, since measures aimed at reducing
30-day readmissions rates were put in place, many
states have witnessed a remarkable reduction in the
number of patient rebounds with about 50% of
states now recording excess readmission ratio of
one or less than 1.0 (Figure 01).
Figure 01: Excess readmission rates by State (Data obtained from CMS)
-
SYMPTOM TRACKING TOOLS
As evidenced from studies, readmissions are
related to the quality of care. It is also evident that
interventions such as tracking patients symptoms using symptom tracking tools can reduce the rates
of 30-day readmissions. It is therefore, prudent to
consider using an all-condition rate of admission as
a measure of quality of care.
V. WHAT CAN BE DONE TO PREVENT READMISSIONS AND THEIR ASSOCIATED
COSTS?
It is now clear that reducing avoidable
readmissions is a challenge to health care
organizations and the U.S government. Even after
implementing EHRs and other measures aimed at
reducing the rate of readmissions, the number of
complications resulting from hospital readmissions
is still worrying. Recent CMS data [11] on the
number of hospitals at which complications occur
reveals that the number of hospitals with the same
or worse complications far exceed the number of
hospitals with better and fewer complications.
This represents a unique opportunity for payers,
providers, and policy makers. They have to come
up with strategies to help reduce the increasing
costs of readmissions while increasing the safety of
patients and the quality of health care. Identifying
policy levers and ideal practices to help reduce
avoidable hospital readmissions would most likely
decrease unnecessary health care costs and
utilizations. It would promote patient-centered care,
improve quality of care, and increase value of the
health care systems.
There is, therefore, the need to consider other
measures to help reduce these hospital
readmissions. Studies have suggested that hospitals
should adopt symptom tracking tools to help
prevent the readmissions and their associated costs.
Tracking symptoms of diseases that contribute to
high hospital readmission can help prevent and
reduce these readmissions. Most recent data from
the Center of Medicare and Medicaid Services
(CMS) reveals that among the key contributors of
increased hospital readmissions include accidental
cuts and tears from medical treatment, Acute
Myocardiac Infraction (AMI), Heart Failure (HF),
Pneumonia (PN), and hip-knee surgery (Figure 02).
The deaths occurring among patients with serious
yet treatable complications after surgery (Figure
02) can also be reduced by use of symptom
tracking tools to track symptoms that are likely to
increase the occurrence of such complications.
Figure 02: Readmission complications (Data
obtained from CMS)
Furthermore, the most recent data from the
Centers for Medicare and Medicaid Services
(CMS) reveal that the use of symptom tracking
tools can potentially help reduce the Excess
readmission ratio from more than 1.0 to less than
0.8 (Figure 03).
Figure 03: Hospital Reduction Readmissions (Data
obtained from CMS)
-
SYMPTOM TRACKING TOOLS 6
The effective use of symptoms tracking tools to
track symptoms or illness-related issues have been
demonstrated in several studies. Rockwood et al
[25] sought to find out whether symptom tracking
tools could effectively be used to track dementia
stage. They used clinical data obtained from a
known stage of dementia to come up with a model
that classifies a persons stage of dementia basing on the symptoms profile. Their results revealed that
symptoms targeted by care partners for online
tracking can be effectively used to stage dementia.
Weiss [24] used a computer-administered interview
to identify and track symptoms and assess
treatment outcomes. The objective was to
determine the efficacy, reliability, and validity of
the Symptoms of Schizophrenia (SOS) inventory.
Weiss designed the Symptoms of Schizophrenia
(SOS) Inventory self-report instrument to be used
by schizophrenia and schizoaffective disorders
patients. The researcher used the VA Medical
Center inpatient wards and Louis Stokes Cleveland
outpatient psychiatric clinics with a sample
population of 138 veterans with diagnosis of
schizoaffective or schizophrenia disorder. The
study measurements were based on the scores of
the Symptoms of Schizophrenia Inventory and the
Colorado Symptom Index (CSI). Weiss found
reliable differences between outpatients and
inpatients (t=3.56, p
-
SYMPTOM TRACKING TOOLS 7
focused, (2) defining the objectives of the app, (3)
evaluating the potential needs of the users, (4)
brainstorming the use-case modeling and app
features, (5) reviewing existing prototypes and app
features, (6) refining functionalities (7) writing the
user narratives, (8) visualizing feature and
navigation design, and (9) identifying the content.
The project outcome included selecting the
following app features: medication reminders and
appointment reminders, a medical summary, a
social media component, easy navigation, symptom
tracking, personalization, gamification, and
informal content. Hermansen-Kobulnisky and
Purtzer [30] showed that patients need to keep
track of their illness-related issues. The author
intended to create awareness of potential
shortcomings and opportunities of patient self-
monitoring for clinical practice. Schaefer et al [31]
sought to determine whether experimentally
increasing the interceptive accuracy can increase
the severity of symptom in somatoform disorder.
The study found that improving heartbeat
perception among patients who have medically
unexplained symptoms can reduce symptom
distress. The findings of this study suggest an
association between perception of symptoms in
somatoform disorders and lower interceptive
accuracy.
VI. CONCLUSION
When the relevant information is put into a
dashboard, care and leadership management teams
can quickly review the outcomes. Organizations
can use this to take immediate actions. The
dashboard illustrates the performance at the
aggregate level from which information can be
segmented based on key factors including: payer,
facility, diagnosis segment, and market. For
providers who work under the fee-for-value
arrangements and other accountable care
organizations, costs associated with emergency and
inpatient department readmissions are too high to
leave unmanaged. Reducing and managing
readmissions starts with having the right tool to
track relevant data and patient symptoms.
Adopting Symptom Tracking tools is a novel idea
for healthcare providers. Symptom tracking tools
can help further prevent and reduce hospital
readmissions. As clearly demonstrated, the
potential use of Symptom Tracking Tools to track
symptoms or illness-related issues can boost the
countrys effort to reduce expenditure on health. Policy makers, providers, and healthcare centers
should encourage the use of Symptom Tracking
Tools as a new strategy to prevent and reduce
hospital readmissions.
REFERENCES
[1] Adrian, A., Benbassat, J.. & Taragin, M. (2010).
Hospital Readmissions as a Measure of Quality of Health Care, Archives of Internal Medicine, 160 (8): 1074-81.
[2] McDonald, A.D. Kind, A. Sunderam, T., Bralla,
Malnick, & Schattner, K. (2008). Bouncing Back: Patterns and Predictors of Complicated Transitions
Thirty Days after Hospitalizations for Acute Ischemic
Stroke, Journal of the American Geriatrics Society, 55 (3): 365-73.
[3] Balla, K., Wennberg, J.E. Malnick, L., & Schattner,
K. (2008). Tracking the Care of Patients with Severe
Chronic Illness: The Dartmouth Atlas of Health Care
2008.Lebanon, NH: The Dartmouth Institute for
Health Policy and Clinical Practice.
[4] Jencks,N., Williams, N., Coleman, P., & Wolff, J.
(2009). Prevalence, Expenditures, and Complications of Multiple Chronic Conditions in the
Elderly, Archives of Internal Medicine, 162, (20): 2269-76.
[5] Pham, H.H. (2007). Care Patterns in Medicare and Their Implications for Pay for Performance, New England Journal of Medicine, 356 (11): 1130-9.
[6] Hunter, T., Nelson J.R., & Birmingham, J. (2013).
Preventing readmissions through comprehensive
discharge planning. Prof Case Manage.18(2):56-63
[7] Optum (2012). Preventing patient rebounds.
Retrieved on 3rd Sept 2014 from http//:
www.optum.com/aco
[8] Optum (2012). Preventing patient Rebounds.
Retrieved on 30th Sept 2014 from
http://www.optum.com/content/dam/optum/resources
/whitePapers/preventing.patient.rebounds.pdf.
[9] Coffey, M.D. (2010). Treatment challenges after discharge, Web M&M: Mortality and Morbidity Rounds on the Web (website), Agency for Healthcare
Research and Quality. Retrieved on 30th Sept 2014
from http://webmm.ahrq.gov/case.aspx?caseID=227
[10] Minott, J. (2008). Reducing Hospital Read missions.
Retrieved on 3rd Sep 2014 from
www.academyhealth.org
[11] Office of Information Products and Data Analytics
Centers for Medicare and Medicare Services.
National Medicare Readmission Findings Recent
Date and Trends. Retrieved on 30th Sept 2014 from
http://www.academyhealth.org/files/2012/sunday/bre
nnan.pdf
[12] Centers for Medicare and Medicaid Services. (2012)
National Medicare Readmission Findings: Recent Data and Trends. Presented on June 24, 2012 by Niall Brennan at the AcademyHealth Annual
Research Meeting. Retrieved on 3rd Sep 2014 from
http://www.academyhealth.org/files/2012/sunday/bre
nnan.pdf
[13] Lauren, M. & Wier, et al. (2008). All Cause Readmissions by Payer and Age, HCUP Statistical Brief 115 (Rockville, MD: Agency for Healthcare
Quality and Research, June 2011). Retrieved on 3rd
Sep 2014 from http://www.hcup-
us.ahrq.gov/reports/statbriefs/sb115.pdf.
[14] Optum. (2011). Nationwide database of large, self-
insured employers encompassing 6.3 million covered
-
SYMPTOM TRACKING TOOLS 8
lives, using the 2011 plan year data. Retrieved on 3rd
Sep 2014.
[15] Aetna. (2011).Aetna, Genesis HealthCare Take Aim at Preventing Hospital Readmissions, news release, 10 August, 2011. Retrieved on 3rd Sep 2014
from
http://www.aetna.com/news/newsReleases/2011/0810_A
etna-Genesis_HospitalReadmissions.html.
[16] Adamy, J. (2011). WellPoint Shakes Up Hospital Payments. Wall Street Journal. Retrieved on 3rd Sep 2014 from
http://online.wsj.com/article/SB10001424052748704281
504576325163218629124.html
[17] UnitedHealth Group. (2012). UnitedHealthcare, Dovetail Health launch innovation program to reduce
the unnecessary hospital readmissions in New
Jersey, Retrieved on 3rd Sep 2014 from http://www.unitedhealthgroup.com/newsroom/news.a
spx?id=4d84b4b9-958b-4b36-a711-4f13b7a69155
[18] Catlin, A. et al. (2008). National Health Spending in 2006: A Year of Change for Prescription Drugs, Health Affairs, January/February, 27, (1), 14-29.3.
[19] Medicare Payment Advisory Commission. (2006).
Healthcare Spending and the Medicare Program: A
Data Book. Washington, DC: Medicare Payment
Advisory Commission, p. 9.4
[20] Medicare Payment Advisory Commission. (2007).
Report to the Congress: Promoting Greater
Efficiency in Medicare. Washington, DC: Medicare
Payment Advisory Commission, p. 103.
[21] Weller, W., Hwang, W., Ireys, H., & Anderson, G.
(2003). Out-of-pocket medical spending for care of
chronic conditions. Health Affairs,20:267-78
[22] Commonwealth Fund (2006). Hospital Readmission Rates for Cohorts of Medicare
Beneficiaries in Boston and New Haven, New England Journal of Medicine, 331 15): 989-95.
[23] Naylor, M.D. (1999). Comprehensive Discharge Planning and Home Follow-up of Hospitalized
Elders, Journal of the American Medical Association, 281 (7): 613-20.
[24] Weiss, K.M.A. (2005). Computerized self-report
symptom distress inventory: for use as a routine
clinical interview in schizophrenia. Psychiatry
(Edgmont), 2 (10):47-55.
[25] Rockwood, K., Schaefer, R.M., Egloff, B., Gerlach,
A.L., Witthft, M.M., Leibman, C., Mucha, L.,
Mitnitski, A. (2013). Staging dementia from
symptom profiles on a care partner website. Journal
of Med Internet Res. 3, 45-76.
[26] Patel, R.A., Klasnja, P., Hartzler, A., Unruh, K.T.,
Pratt, W. (2012). Probing the benefits of real-time
tracking during cancer care.AMIA Annu Symp Proc. 2
(1):1340-9.
[27] Orenstein, S.R. (2010). Symptoms and reflux in
infants: Infant Gastroesophageal Reflux
Questionnaire Revised (I-GERQ-R)--utility for
symptom tracking and diagnosis. Curr Gastroenterol
Rep, 12(6):431-6.
[28] Giarelli, E., Bernhardt, B.A., & Pyeritz, R.E. (2010).
Self-surveillance by adolescents and young adults
transitioning to self-management of a chronic genetic
disorder. Health Education Behavior, 37(1):133-50.
[29] Herschman, J., Kasenberg, T., Levy, D., Ruth, N.,
Taberner, C., Kaufman, M., Regina, A. (2014).
Development of a smartphone app for adolescents
with lupus: a collaborative meeting-based
methodology inclusive of a wide range of
stakeholders. Rev Panam Salud Publica, 35(5-
6):471-6
[30] Hermansen-Kobulnicky, C.J., & Purtzer, M.A.
(2014). Tracking and journaling the cancer journey.
Clin Journal of Oncol Nurs, 18(4):388-91.
[31] Schaefer, M., Egloff, B., Gerlach, A.L., & Witthft,
M. (2014). Improving heartbeat perception in patients
with medically unexplained symptoms reduces
symptom distress. Biol Psychol, 101:69-76.
[32] Ben-Bassat, H., &Klein, B.Y. (2000). Inhibitors of
tyrosine kinases in the treatment of psoriasis. Curr
Pharm Des 6:933942. [33] Yoos, H.L., McMullen, A. (1999). Symptom
perception and evaluation in childhood asthma. Nurs
Res, 48(1):2-8.